Corrigendum to: "Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer" [Int. J. Biol Macromol. 245 (2023) Jun 21; 125510/Online ahead of print. PMID: 37353120; IJBIOMAC-D-23-03903R1]

Int J Biol Macromol. 2023 Sep 1:248:125782. doi: 10.1016/j.ijbiomac.2023.125782. Epub 2023 Jul 21.
No abstract available

Publication types

  • Published Erratum